Haiying Sun
China Pharmaceutical University(CN)Xuzhou Medical College(CN)Guangdong Pharmaceutical University(CN)University of Florida(US)First Hospital of China Medical University(CN)Tongji Hospital(CN)Huazhong University of Science and Technology(CN)China Medical University(CN)
Publications by Year
Research Areas
Cell death mechanisms and regulation, ATP Synthase and ATPases Research, Cervical Cancer and HPV Research, CAR-T cell therapy research, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients(2020)381 cited
- → Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors(2021)337 cited
- → Drug efflux transporters in the CNS(2003)302 cited
- → A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment(2011)267 cited
- → SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP(2008)200 cited
- → Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP